FXR Agonist INT-747 Upregulates DDAH Expression and Enhances Insulin Sensitivity in High-Salt Fed Dahl Rats

Yohannes T. Ghebremariam, Keisuke Yamada, Jerry C. Lee, Christine L.C. Johnson, Dorothee Atzler, Maike Anderssohn, Rani Agrawal, John P. Higgins, Andrew J. Patterson, Rainer H. Böger, John P. Cooke

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Aims:Genetic and pharmacological studies have shown that impairment of the nitric oxide (NO) synthase (NOS) pathway is associated with hypertension and insulin-resistance (IR). In addition, inhibition of NOS by the endogenous inhibitor, asymmetric dimethylarginine (ADMA), may also result in hypertension and IR. On the other hand, overexpression of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme that metabolizes ADMA, in mice is associated with lower ADMA, increased NO and enhanced insulin sensitivity. Since DDAH carries a farnesoid X receptor (FXR)-responsive element, we aimed to upregulate its expression by an FXR-agonist, INT-747, and evaluate its effect on blood pressure and insulin sensitivity.Methods and Results:In this study, we evaluated the in vivo effect of INT-747 on tissue DDAH expression and insulin sensitivity in the Dahl rat model of salt-sensitive hypertension and IR (Dahl-SS). Our data indicates that high salt (HS) diet significantly increased systemic blood pressure. In addition, HS diet downregulated tissue DDAH expression while INT-747 protected the loss in DDAH expression and enhanced insulin sensitivity compared to vehicle controls.Conclusion:Our study may provide the basis for a new therapeutic approach for IR by modulating DDAH expression and/or activity using small molecules.

Original languageEnglish (US)
Article numbere60653
JournalPloS one
Volume8
Issue number4
DOIs
StatePublished - Apr 4 2013

Fingerprint

Inbred Dahl Rats
insulin resistance
agonists
Insulin Resistance
Rats
Up-Regulation
Salts
Insulin
salts
receptors
rats
hypertension
Blood pressure
Nutrition
Hypertension
Nitric Oxide Synthase
blood pressure
Tissue
Diet
Blood Pressure

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Ghebremariam, Y. T., Yamada, K., Lee, J. C., Johnson, C. L. C., Atzler, D., Anderssohn, M., ... Cooke, J. P. (2013). FXR Agonist INT-747 Upregulates DDAH Expression and Enhances Insulin Sensitivity in High-Salt Fed Dahl Rats. PloS one, 8(4), [e60653]. https://doi.org/10.1371/journal.pone.0060653

FXR Agonist INT-747 Upregulates DDAH Expression and Enhances Insulin Sensitivity in High-Salt Fed Dahl Rats. / Ghebremariam, Yohannes T.; Yamada, Keisuke; Lee, Jerry C.; Johnson, Christine L.C.; Atzler, Dorothee; Anderssohn, Maike; Agrawal, Rani; Higgins, John P.; Patterson, Andrew J.; Böger, Rainer H.; Cooke, John P.

In: PloS one, Vol. 8, No. 4, e60653, 04.04.2013.

Research output: Contribution to journalArticle

Ghebremariam, YT, Yamada, K, Lee, JC, Johnson, CLC, Atzler, D, Anderssohn, M, Agrawal, R, Higgins, JP, Patterson, AJ, Böger, RH & Cooke, JP 2013, 'FXR Agonist INT-747 Upregulates DDAH Expression and Enhances Insulin Sensitivity in High-Salt Fed Dahl Rats', PloS one, vol. 8, no. 4, e60653. https://doi.org/10.1371/journal.pone.0060653
Ghebremariam YT, Yamada K, Lee JC, Johnson CLC, Atzler D, Anderssohn M et al. FXR Agonist INT-747 Upregulates DDAH Expression and Enhances Insulin Sensitivity in High-Salt Fed Dahl Rats. PloS one. 2013 Apr 4;8(4). e60653. https://doi.org/10.1371/journal.pone.0060653
Ghebremariam, Yohannes T. ; Yamada, Keisuke ; Lee, Jerry C. ; Johnson, Christine L.C. ; Atzler, Dorothee ; Anderssohn, Maike ; Agrawal, Rani ; Higgins, John P. ; Patterson, Andrew J. ; Böger, Rainer H. ; Cooke, John P. / FXR Agonist INT-747 Upregulates DDAH Expression and Enhances Insulin Sensitivity in High-Salt Fed Dahl Rats. In: PloS one. 2013 ; Vol. 8, No. 4.
@article{4fb39638e9474a39bd44127dd1bcc2da,
title = "FXR Agonist INT-747 Upregulates DDAH Expression and Enhances Insulin Sensitivity in High-Salt Fed Dahl Rats",
abstract = "Aims:Genetic and pharmacological studies have shown that impairment of the nitric oxide (NO) synthase (NOS) pathway is associated with hypertension and insulin-resistance (IR). In addition, inhibition of NOS by the endogenous inhibitor, asymmetric dimethylarginine (ADMA), may also result in hypertension and IR. On the other hand, overexpression of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme that metabolizes ADMA, in mice is associated with lower ADMA, increased NO and enhanced insulin sensitivity. Since DDAH carries a farnesoid X receptor (FXR)-responsive element, we aimed to upregulate its expression by an FXR-agonist, INT-747, and evaluate its effect on blood pressure and insulin sensitivity.Methods and Results:In this study, we evaluated the in vivo effect of INT-747 on tissue DDAH expression and insulin sensitivity in the Dahl rat model of salt-sensitive hypertension and IR (Dahl-SS). Our data indicates that high salt (HS) diet significantly increased systemic blood pressure. In addition, HS diet downregulated tissue DDAH expression while INT-747 protected the loss in DDAH expression and enhanced insulin sensitivity compared to vehicle controls.Conclusion:Our study may provide the basis for a new therapeutic approach for IR by modulating DDAH expression and/or activity using small molecules.",
author = "Ghebremariam, {Yohannes T.} and Keisuke Yamada and Lee, {Jerry C.} and Johnson, {Christine L.C.} and Dorothee Atzler and Maike Anderssohn and Rani Agrawal and Higgins, {John P.} and Patterson, {Andrew J.} and B{\"o}ger, {Rainer H.} and Cooke, {John P.}",
year = "2013",
month = "4",
day = "4",
doi = "10.1371/journal.pone.0060653",
language = "English (US)",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "4",

}

TY - JOUR

T1 - FXR Agonist INT-747 Upregulates DDAH Expression and Enhances Insulin Sensitivity in High-Salt Fed Dahl Rats

AU - Ghebremariam, Yohannes T.

AU - Yamada, Keisuke

AU - Lee, Jerry C.

AU - Johnson, Christine L.C.

AU - Atzler, Dorothee

AU - Anderssohn, Maike

AU - Agrawal, Rani

AU - Higgins, John P.

AU - Patterson, Andrew J.

AU - Böger, Rainer H.

AU - Cooke, John P.

PY - 2013/4/4

Y1 - 2013/4/4

N2 - Aims:Genetic and pharmacological studies have shown that impairment of the nitric oxide (NO) synthase (NOS) pathway is associated with hypertension and insulin-resistance (IR). In addition, inhibition of NOS by the endogenous inhibitor, asymmetric dimethylarginine (ADMA), may also result in hypertension and IR. On the other hand, overexpression of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme that metabolizes ADMA, in mice is associated with lower ADMA, increased NO and enhanced insulin sensitivity. Since DDAH carries a farnesoid X receptor (FXR)-responsive element, we aimed to upregulate its expression by an FXR-agonist, INT-747, and evaluate its effect on blood pressure and insulin sensitivity.Methods and Results:In this study, we evaluated the in vivo effect of INT-747 on tissue DDAH expression and insulin sensitivity in the Dahl rat model of salt-sensitive hypertension and IR (Dahl-SS). Our data indicates that high salt (HS) diet significantly increased systemic blood pressure. In addition, HS diet downregulated tissue DDAH expression while INT-747 protected the loss in DDAH expression and enhanced insulin sensitivity compared to vehicle controls.Conclusion:Our study may provide the basis for a new therapeutic approach for IR by modulating DDAH expression and/or activity using small molecules.

AB - Aims:Genetic and pharmacological studies have shown that impairment of the nitric oxide (NO) synthase (NOS) pathway is associated with hypertension and insulin-resistance (IR). In addition, inhibition of NOS by the endogenous inhibitor, asymmetric dimethylarginine (ADMA), may also result in hypertension and IR. On the other hand, overexpression of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme that metabolizes ADMA, in mice is associated with lower ADMA, increased NO and enhanced insulin sensitivity. Since DDAH carries a farnesoid X receptor (FXR)-responsive element, we aimed to upregulate its expression by an FXR-agonist, INT-747, and evaluate its effect on blood pressure and insulin sensitivity.Methods and Results:In this study, we evaluated the in vivo effect of INT-747 on tissue DDAH expression and insulin sensitivity in the Dahl rat model of salt-sensitive hypertension and IR (Dahl-SS). Our data indicates that high salt (HS) diet significantly increased systemic blood pressure. In addition, HS diet downregulated tissue DDAH expression while INT-747 protected the loss in DDAH expression and enhanced insulin sensitivity compared to vehicle controls.Conclusion:Our study may provide the basis for a new therapeutic approach for IR by modulating DDAH expression and/or activity using small molecules.

UR - http://www.scopus.com/inward/record.url?scp=84875939618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875939618&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0060653

DO - 10.1371/journal.pone.0060653

M3 - Article

C2 - 23593273

AN - SCOPUS:84875939618

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 4

M1 - e60653

ER -